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Approximately 53 million Americans live with a disability. For decades, theNational Institutes of Health (NIH) has been conducting and supporting
research to discover new ways to minimize disability and enhance the quality of
life of people with disabilities. After the passage of the American With Disabilities
Act, the NIH established the National Center for Medical Rehabilitation Research
with the goal of developing and implementing a rehabilitation research agenda.
Currently, a total of 17 institutes and centers at NIH invest more than $500 million
per year in rehabilitation research. Recently, the director of NIH, Dr. Francis
Collins, appointed a Blue Ribbon Panel to evaluate the status of rehabilitation
research across institutes and centers. As a follow-up to the work of that panel, NIH
recently organized a conference under the title “Rehabilitation Research at NIH:
Moving the Field Forward.” This report is a summary of the discussions and
proposals that will help guide rehabilitation research at NIH in the near future.
The conference took place at the NIH Campus on May 25 and 26, 2016. It
was cosponsored by the Eunice Kennedy Shriver National Institute of Child
Health and Human Development, the National Institute of Biomedical Imaging
and Bioengineering, the National Institute of Neurological Diseases and Stroke,
the National Institute of Nursing Research, the National Institute on Deafness
and Other Communication Disorders, the National Center for Complementary
and Integrative Health, and the Office of Disease Prevention. The main ob-
jectives of the conference were to (1) discuss the current NIH portfolio in
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rehabilitation research, (2) highlight advances in reha-
bilitation research supported by NIH, and (3) provide an
opportunity for scientists and the general public to com-
ment on gaps in knowledge, opportunities for training, and
infrastructure needs. The program included a total of 13
expert panels, four remarks by NIH leaders, a consumer
keynote, a town hall, a poster session, and the use of social
media to disseminate information in real time. The fol-
lowing is a summary of the discussion, and the subheadings
correspond to the titles of the expert panels.
Rehabilitation Across the Lifespan
(Moderator: Alan Jette, PhD, Boston University; panelists:
Andrea Cheville, MD, Mayo Clinic; Jonathan Bean, MD,
Boston University; Shari Wade, PhD, Cincinnati Children’s
Hospital Medical Center)
The theme of this session was moving rehabilitation in-
terventions from a traditional “one-and-done” isolated
model of care to one where rehabilitation interventions are
integrated into the mainstream of health care. The speakers
addressed integrated care approaches in cancer care, pri-
mary care, and pediatric rehabilitation.
Barriers to integrating function-directed care into the
comprehensive management of progressive diseases, par-
ticularly those with a heavy treatment burden, were iden-
tified. Cancer was used an exemplar of the simultaneously
dynamic and insidious nature of disablement in chronic
illness. Collaborative care approaches, including telecare,
validated for pain and depression management, were
considered a promising means to proactively and patient-
centrically address cancer-related disablement. Current
research in cancer rehabilitation suggests that challenges
revolve around issues such as patient selection and timing,
when and how to intervene, limitations of linear impairment-
to-disability models (with multiple mild impairments
the norm), and competition with disease-modifying ther-
apies. Although functional limitations are prevalent (seen
in 65% of all cancer patients), rehabilitation intervention
remains underused. In contrast to ischemic and traumatic
injuries, rehabilitation interventions in patients with cancer
are less prescriptive, more negotiable, and subject to patient
preferences. Current care delivery overwhelmingly emphasizes
primary disease management.
Another presentation focused on limitations with
mobility tasks, such as walking, rising from a chair, or
climbing stairs, as a signal condition identifying older adult
primary care patients at an increased risk for disability,
morbidity, and death. It was discussed how rehabilitative
care can play a critical role with older adult primary care
patients by developing integrated care paradigms between
primary and rehabilitative care providers focused on
prevention of mobility decline among older adults. Pre-
vention of adverse health outcomes represents a new
conceptual role for rehabilitative care. Research priorities
include determining the optimal content and design of
preventative rehabilitative care; the potential benefits for
patients, families, and health care organizations; and the
cost–benefit of such approaches to care.
Traumatic brain injury (TBI) was used as a case ex-
ample to discuss the need for further research on ways to
integrate pediatric rehabilitation into the broader frame-
work of child development. TBI is currently viewed as a
discrete event with time-limited consequences while evi-
dence from the TBI Model Systems suggests lifelong
physical and cognitive consequences. Long-term pediatric
studies are lacking, but existing evidence suggests long-term
effects on educational attainment and vocational and social
success. However, after the postacute recovery phase,
children with TBI receive little ongoing rehabilitation. TBI-
related problems that emerge with shifting developmental
demands may go unrecognized or be inaccurately charac-
terized. Families and schools constitute powerful contexts
for ongoing rehabilitation and later habilitation. How
families function and interact with the child exerts a
powerful influence on the recovery trajectory. Interventions
need to be developmentally tailored and address the current
developmental and neural context. Challenges remain in
framing rehabilitation/habilitation as an ongoing process
with tune-ups at various developmental stages rather than
a one-and-done model. A better understanding of adult
outcome metrics (e.g., education and employment) and
long-term burden (disability and life quality) is needed. To
reduce heterogeneity and improve prediction, research is
needed to better categorize the initial injury/insult along
with better understanding of effects on neurodevelopment
and how this relates to long-term functional outcomes.
Multicenter consortia are urgently needed to support larger
scale outcome studies and provide an infrastructure to link
school and medical data as well as study interventions and
management practices more efficiently.
Technology in Rehabilitation: From
Cutaneous to Implanted
(Moderator: Ranu Jung, PhD, Florida International Uni-
versity; panelists: Leigh Hochberg, MD, PhD, Harvard
University; Reggie Edgerton, PhD, University of California,
Los Angeles; Joseph Rizzo, MD, Harvard University; Mario
Svirsky, PhD, New York University)
Innovation and advances in engineering and computing
are having a ubiquitous impact on health and well-being.
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The purpose of this panel was to discuss the challenges and
opportunities for developing technologies that interface
with the nervous system at an appropriate level, are user
centric and responsive to the ability of the user and their
life span, and could provide new neuroscience insights to
inform rehabilitation science. The panel also discussed the
importance of having appropriate assessment methodol-
ogies and comprehensive engagement with regulatory, in-
dustry, and clinical partners. The moderator and panelists
brought to the discussion their experience as neuroscien-
tists, biomedical engineers, and clinical practitioners, some
with personal experience of moving neurotechnology from
the laboratory to human studies. Using examples from
engineering of cochlear and visual prosthetic devices and
brain, spinal cord, and peripheral nerve interfaces, they
discussed the role of technology in scientific discovery and
recovery and restoration of missing or lost function.
The overall span of the technology that can influ-
ence rehabilitation is broad: from assistive devices, re-
habilitation robotics, and implanted neuroprostheses to
augmented connectivity between people and devices, use
of virtual reality environments for training, and use of
mobile health and telehealth platforms for deployment of
rehabilitative therapies. The panel discussions focused on
implanted neuroprostheses. Advances in neurotechnology
will allow better access to information about the living
system at multiple scales, from cellular to behavioral. Im-
proved understanding of the endogenous activity patterns
of neural activity could help guide the design of neuro-
prostheses that can more precisely influence and modify the
neural activity to initiate and sustain long-term beneficial
neuroplasticity leading to repair or recovery. Design, de-
velopment, and deployment of the neuroprostheses that
form biohybrid systems with the living body have many
challenges.
Amajor challenge in the deployment of neuroprostheses
that affect recovery is to make the neuroprostheses adaptive
and patient centric. The scheduling (timing) for introducing
rehabilitation technology to patients after a traumatic event
is very important. In addition, whether all of the capabilities
for the neurotechnology should be introduced immediately
or in a controlled sequential manner after deployment has
to be considered. For example, after a bilateral sequential
implantation of cochlear implants, should they be deployed
sequentially or together? To restore function after incom-
plete spinal cord injury (SCI), should epidural stimulation
be conducted in parallel with or before treadmill training?
Recovery of function is very patient specific and may
confound assessment of the effectiveness of different neural
stimulation paradigm interventions. To design appropriate
rehabilitation therapies, conduction of scientific studies in
tandem with technology development would be highly
beneficial. This in itself raises new challenges.
Several of the technological interventions could re-
quire extensive development, and the underlying science
of rehabilitation may be insufficient to support the use of
these technologies for larger scale human use. It is essential
that early development of neurotechnologies, including
the scientific studies that provide the evidence, are con-
ducted with close consultation of the regulatory bodies,
such as the Food and Drug Administration. Safety and
reliability in small early-feasibility trials need to be con-
sidered. In this context, the panel suggested that for se-
quential improvements in technology, a modular design
be used. In addition, giving the participant at least some
control over use of the technology as needed was con-
sidered important. This requires the development of a
regulatory acceptance pathway.
There was considerable discussion on the design of
study protocols with small numbers of enrolled partici-
pants. Each participant’s own abilities with turning on or
shutting off the device could be used as an internal control
for device evaluation, thereby formalizing and extending
the value of small studies. The lack of commercial support
for conducting small-sample studies with the associated
legal and regulatory requirements indicates that govern-
ment funding support for technology development and
early-feasibility trials is paramount for translation of the
neurotechnologies from the laboratory to the clinic.
A key outcome from the panel discussion was that
implanted neurotechnologies offer a “precision medicine”
approach to rehabilitation. They target specific neural
populations. The stimulation paradigms could be com-
bined with other treatments, especially cell therapies, to
maximize function. This ability for precision deployment
could be further tailored to take advantage of the genetic
makeup of the recipient to make it a personalized, adaptive
approach to rehabilitation.
Mechanisms and Markers of Activity
and Function
Exercise, Plasticity, and Mechanism: How Is
Rehabilitation Happening?
(Moderator: Keith Tansey, MD, PhD, Methodist Rehabilitation
Center; panelists: Rick Lieber, PhD, Rehabilitation Institute of
Chicago; Stephen Seliger, MD, University of Maryland; James
Blumenthal, PhD, Duke University)
Rehabilitation interventions are applied to various patient
populations with diverse physiological profiles over ex-
tended periods with relatively little evidence regarding
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how which interventions are doing what in whom. Pa-
tients with neurological problems need to be characterized
better so that we can identify and analyze responders versus
nonresponders. Monitoring tools to ensure that rehabil-
itation interventions are proceeding toward more normal
physiology over time are also needed.
Neurological plasticity after injury can be both adaptive
and maladaptive, and we need to work to gain the former
while limiting the latter. Similarly, skeletal muscle plas-
ticity is important in injury and rehabilitation, but classic
measures rarely capture the functionally relevant properties
of skeletal muscle. Most plasticity studies focus on muscle
active properties such as force generation and fatigue and
less so on problems involving passive mechanical properties
due to contracture or fibrosis. New areas of investigation in
the field include extracellular matrix structure and function
and the development of new imaging methods that would
permit mesoscale quantitative measures of muscle perfor-
mance that are objective and clinically relevant.
Older adults with chronic kidney disease have im-
paired neurocognitive function, physical performance, and
aerobic capacity. Research has been done on the mecha-
nisms associating kidney disease with physical and cognitive
impairment. Exercise training improves neurocognitive
function and protects against cognitive decline in chronic
renal disease patients.
Finally, patients undergoing cardiac rehabilitation
benefit from stress management. The Enhancing Cardiac
Rehabilitation With Stress Management Training trial
shows the beneficial effects of combining stress manage-
ment training with standard exercise-based cardiac re-
habilitation in terms of stress levels, coronary heart disease
biomarkers, and clinical outcomes. These findings should
be disseminated, and cardiac rehabilitation programs in-
cluding stress management should be made more acces-
sible to patients with coronary heart disease.
The major issues identified and questions raised in
this session for further consideration going forward were
as follows: We have to address diverse populations (phy-
siologically) in rehabilitation, even within a given diag-
nosis. We also need to address our lack of mechanistic
understanding of interventions, in preclinical and clini-
cal scenarios, which makes predicting responders versus
nonresponders difficult and makes translation from ani-
mal model to human problematic as well. The idea of
tracking progression during an intervention was intro-
duced: Are we generating more normal biology/function
or developing “work-arounds” in rehabilitation? The ques-
tion was raised as to whether we are measuring the right
biological markers in our systems, the ones that are actually
critical to the pathophysiology/impaired function, so as to
develop appropriate interventions. We may need to develop
better assessment tools (imaging for instance) to understand
these issues. We may also need to connect previously un-
connected areas of medicine (chronic disease states and
their neurological impact for instance) to make a wider
impact with our interventions. Finally, we should part-
ner psychological interventions with rehabilitation in-
terventions to have a greater impact overall on human
health.
Access to the Lived Environment
(Moderator: Melanie Fried-Oken, PhD, Oregon Health &
Science University; panelists: Cole Galloway, PhD, Uni-
versity of Delaware; Maureen Schmitter-Edgecombe, PhD,
Washington State University; James Coughlan, PhD,
Smith–Kettlewell Eye Research Institute)
This panel presented and discussed evidence that assistive
technologies (ATs) provide functional tools to ensure that
individuals experience their greatest level of functional
independence in daily life. Based on the International
Classification of Functioning, Disability and Health (ICF )
of the World Health Organization, AT is a facilitator for
activities and participation for individuals who experience
disability and chronic health conditions. The technolo-
gies being developed, discussed, and tested by this panel
are often mainstream technologies available to the general
public that are adapted to meet functional needs and
provide access to daily environments. Devices such as off-
the-shelf toy racecars that can provide mobility to chil-
dren with physical impairments, environmental controls
with infrared sensors to support or assess older adults
with dementia who are aging in place, and application
software for touch tablets and mobile phones that guide
travelers with visual impairments at traffic intersections
were discussed and demonstrated through multimedia
presentations.
The panel discussed three common themes and a
number of challenges to the design, testing, and imple-
mentation of ATs, including the following:
1. Participatory action research is a critical element of
rehabilitation research. Individuals with disabilities
must be included in all stages of hypothesis testing
and analysis to ensure content validity. Participatory
action research is sensitive to group as well as individ-
ual differences (e.g., cultural, ethnic, lifestyle diversity)
and leads to people having increased control over their
lives.
2. The utility of AT for value added to end users and
professionals must become a priority for rehabilitation
science. Utility measures such as task performance
(e.g., efficiency and effectiveness of task completion),
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user satisfaction, and quality of life must become stan-
dard. It is challenging to measure value because the
user population is extremely heterogeneous in terms
of needs, abilities, and preferences. Researchers must
determine whether it is better to assess utility for a
narrow population who is most likely to benefit from
AT or for a broad population, where only a subset
of individuals is likely to benefit. The variability of user
population and task conditions can make it very hard
and/or costly to get good statistics on utility. Although
statistical success is easier to obtain under controlled
laboratory conditions, the laboratory conditions do
not translate to real-world conditions. Measurement
of user satisfaction (or dissatisfaction) and quality of
life, constructs that are often used for outcomes, has
challenges as well.
3. AT must be scaled, in terms of sustainability and
accessibility, to the population. As technology is rap-
idly advancing, we must try to get at the back end of it
even as it gets more complex. For example, as infrared
sensors became wireless, laboratories and smart homes
needed to adjust so that our tools are sustainable. For
the biggest impact, one goal in technology research
and development must include keeping products
and services affordable so they can be accessed by
the population who needs them. Likewise, we must
increase awareness and benefits of ATs for the general
public. The AT must meet the environmental and
personal demands of the end users while protecting
privacy and maintaining confidentiality and security
of personal information.
Individuals, Families, and Community
(Moderator: Linda Ehrlich-Jones, PhD, Rehabilitation
Institute of Chicago; panelists: Christopher Murtaugh, PhD,
Visiting Nurse Service of New York; George Alexopoulos,
MD, Cornell University; Sara Czaja, PhD, University of
Miami Miller School of Medicine)
Rehabilitation interventions incorporating the home, the
family, and the community promote active engagement
of patients, family, and community members to achieve
increased quality of life for people with disabilities. Psy-
chosocial interventions aimed at reducing poststroke de-
pression and stress rely on five integrated components: (1)
offer patients an action-oriented “new perspective” about
recovery; (2) provide an “adherence enhancement struc-
ture”; (3) offer a “problem-solving structure” to the pa-
tient focusing on problems, valued by the patient, and
pertinent to daily function; (4) help the patient’s family
“reengineer its goals, involvement, and plans” to accom-
modate the patient’s disability; and (5) “coordinate care
with specialized therapists” with the goal to increase pa-
tient participation in rehabilitation and social activities.
The outcomes of patients receiving physical therapy
at home for activity-limiting pain, total hip or knee re-
placements, and implantable cardiac devices show some
improvement over time. Family caregivers play a critical
role in supporting older adults and family members with
a chronic disease or disability. Intervention strategies that
are aimed at supporting family caregivers and reducing
caregiver burden with an emphasis on technology-based
interventions are needed to facilitate improved outcomes
in people with disabilities. The end goal of incorporating
the home, the family, and the community is greater in-
dependence and providing opportunities for people with
disabilities to actively contribute to their community.
Strategies that help individuals to self-manage their dis-
ability can lead to achievement or maintenance of positive
outcomes. The challenges experienced by caregivers of
individuals with disabilities need further attention.
Gaps and opportunities for future research include
examination of the impact of sociodemographic influ-
ences, including geography, socioeconomic status, edu-
cation, and language/culture, on rehabilitation success.
In addition, development of self-management strategies
that can be implemented in community settings to help
individuals better understand and manage their disability
and achieve or maintain positive quality of life and in-
dependence are necessary areas of future research.
Understanding the Context: Environmental
Impacts in Rehabilitation
(Moderator: Michael Mueller, PhD, Washington University
School of Medicine; panelists: James Burke, MD, University
of Michigan; Amanda Botticello, PhD, MPH, Kessler
Foundation; Patrick Kitzman, PhD, University of Kentucky)
The purpose of this session was to consider how envi-
ronmental factors influence outcomes in rehabilitation.
The “environment” is an important, modifiable, and
understudied element in the ICF framework.
An example was provided of patients with diabetes
and peripheral neuropathy that illustrated how a con-
ceptual framework had been used to help direct inter-
ventions at the environmental level (casting, footwear,
community screening, and education) to reduce the rate
of lower-extremity amputation. Other, more complex
models are being developed to illustrate ways in which race
and socioeconomic factors may interact with contextual
factors such as caregiver support, transportation, neigh-
borhood environment, and social network to limit access
to rehabilitation. Some drivers of racial differences in
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poststroke disability are modifiable, and we should con-
sider stroke survivor– and family-level strategies to reduce
disability and decrease disparities.
There are links between community context and long-
term outcomes for people with SCI. Community char-
acteristics such as socioeconomic disadvantage, resource
deprivation, segregation, and physical inaccessibility likely
threaten the physical, psychological, and social func-
tioning gains achieved during rehabilitation. Neighbor-
hood socioeconomic factors affect health and well-being
over and above personal characteristics. For example,
employment rates for SCI are poor, with rural rates the
lowest, followed by suburban rates, and urban rates the
highest. The best prospects for employment and com-
munity participation are for those people with SCI and
high socioeconomic status in urban environments. The
challenge of providing rehabilitation services to people
with SCI in rural settings was highlighted with a de-
scription of a specific program targeting rural Kentucky,
a state at the bottom of several U.S. health outcomemeasures.
The Kentucky Appalachian Rural Rehabilitation Network
is working to overcome these barriers and encourages a
bidirectional flow of information, providing clear benefits
for the community, being accountable, and providing long-
term commitment (i.e., sustainability) to the community.
All presentations and discussion highlighted the fact
that interactions between environment and outcomes are
highly complex and vary according to location, socio-
economic level, race, age, and disability. Understanding
these complex relationships will require further refinement
of conceptual models and a variety of research approaches
to understand outcomes and devise policy to enhance
outcomes. Big data sets are useful, and the net of these data
sets needs to be spread even further to capture common
concerns across wide geographic areas. Consistent with
other sessions, there is a need for common outcome mea-
sures but also for qualitative studies to better understand
these themes at an individual level.
Finally, another important theme was the need for
ongoing support for people with chronic disabilities.
Longitudinal research is needed to determine how dis-
ability affects people in their environment over time.
Intervention should not be “one and done” but should
dynamically meet the ongoing and changing needs of
people with chronic health problems.
Effective Pathways to Evidence
for Rehabilitation
(Moderator: James Malec, PhD, Indiana University School
of Medicine/Rehabilitation Hospital of Indiana; panelists:
Lynn Snyder-Mackler, PT, ScD, University of Delaware;
Catherine Lang, PhD, Washington University; Susan Horn,
PhD, University of Utah)
This symposium examined phases, options, and challenges
in advancing a line of rehabilitation research. Methodol-
ogies for addressing challenges were explored, as well as for
incorporating mechanisms, defining dose, and examining
the effectiveness of standard rehabilitation procedures.
Traditional phases in a line of research include idea
generation, natural history and/or animal models, early
human testing for safety and feasibility, efficacy trials, and
effectiveness trials. This sequence may be most informative
if viewed as iterative and recursive rather than linear.
Designs such as the randomized controlled trial (RCT)
offer strong internal validity. However, some aspects of the
RCT, for example, participant and researcher blinding and
development of a viable control condition, may be difficult
to implement in rehabilitation research. Other designs,
such as large-scale observational or practice-based evidence
trials, may offer stronger external validity. Balancing in-
ternal and external validity is critical to encourage timely
translation into practice. Other considerations and chal-
lenges in advancing rehabilitation research include het-
erogeneity of participants and interventions (which are
typically individualized in practice), fidelity assurance,
dosing, consideration of nonspecific factors as moderators
as opposed to confounders of treatment effect, and the
precision of measurement tools used to assess outcomes
that are not directly observable and must be assessed by
observer or participant rating.
Investigating the underlying mechanisms of action
in high-quality clinical trials and observational quasi-
experimental studies within rehabilitation research is achiev-
able but fraught with obstacles that do not occur in typical
clinical drug trials. Unlike the delivery of an active med-
ication or placebo, rehabilitation interventions are typically
multimodal and involve active participation of both the
patient and the clinicians. Thus, ensuring fidelity, that is,
defining the intervention(s), ensuring that the intervention(s)
are reliably applied and defining the active component(s),
is particularly challenging in studies of rehabilitation. Use
of fidelity metrics, ideally completed by more than one
observer, addresses this challenge. In rehabilitation research,
outcomes are often complex, occur across the ICF domains,
and include patient-reported as well as performance-based
and instrumented outcomes. Consequently, strategic se-
lection and pretrial testing of precision outcome metrics
and control conditions are critical.
It is also critical to consider dosing in rehabilitation
trials to not waste resources and to eventually improve
outcomes. In rehabilitation, dose is an interaction ofmultiple
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parameters. Explicit studies of dose–response are necessary
to determine essential information about active ingredients,
their biological targets and mechanisms of action, and their
half-lives. As with other elements of high-quality clinical
trials, key dosing parameters are best determined through
pretrial feasibility study. Methods to determine appropriate
dose include careful quantification of the active ingredient,
multiple assessments over the course of the intervention,
multiple groups receiving different doses, and sophisticated
statistical modeling of data across time (e.g., hierarchical
linear modeling, individual growth curve analysis).
Electronic medical records are collecting detailed
patient, treatment, and outcome data now and will do so
even more in the future. This information can be used to
determine those interventions that are associated with
better outcomes for patients with specified sets of char-
acteristics through practice-based evidence study designs.
Practice-based evidence is an example of an innovative re-
search methodology that addresses many of the challenges
to the traditional RCT posed by rehabilitation research.
This session identified a number of challenges to
interventional rehabilitation research, including heterogene-
ity of participants, individualized and complex treatments,
balancing internal and external validity, implementing viable
control conditions, difficulty blinding participants and re-
searchers, nonspecific treatment moderators, fidelity assur-
ance, and dosing. A greater emphasis on pretrial studies and
alternative designs to the traditional RCT offers opportu-
nities to address many of these challenges.
Central and Peripheral Mechanisms
of Rehabilitation
(Moderator: Rick Lieber, PhD, Rehabilitation Institute of
Chicago; panelists: D. Michele Basso, PhD, Ohio State
University; Monica Perez, PhD, University of Miami; Mike
Boninger, MD, University of Pittsburgh)
In this session, the mechanisms of plasticity in rehabili-
tation were discussed. The presenters focused on approaches
to measuring brain, spinal cord, and skeletal muscle func-
tion and discussed how rehabilitation and regenerative
therapies could be applied to improve central and peripheral
function.
Human skeletal muscle adapts to contractures that
occur secondary to stroke and cerebral palsy (CP). Intra-
operative structural studies of upper-extremity muscles show
that sarcomere length increased while serial sarcomere
number decreased dramatically. The extracellular matrix
in contractures was deranged (hypertrophic and altered
composition) and apparently does not support a functional
stem cell niche. Using both flow-assisted cell sorting and
immunohistochemistry, it has been demonstrated that
satellite cell number (muscle stem cells) is decreased by
about 70% in contractures. This may cause muscle
shortening, deranged extracellular matrix, and increased
muscle stiffness. Finally, studies of gene expression from
these muscles revealed altered transcriptional pathways
relative to other models of decreased use such as immo-
bilization, SCI, or spaceflight. Thus, muscle contracture
represents a dramatic and unique model that must be
understood mechanistically to develop novel treatment
approaches.
Studies at the cellular level may explain why SCI
rehabilitation can be quite effective in some individuals
while others show limited improvement. In rodent models
of contusion, the timing to deliver task-specific training
and cellular factors that are conducive to motor learning
has been determined. These findings suggest that in-
flammation in cord regions remote to the injury is a barrier
to effective rehabilitation. In fact, animal models show
that training delivered early after SCI during high in-
flammation worsens function, but reducing this inflam-
mation allows robust locomotor recovery using a brief
training paradigm. The source and genetic profiles of
cellular inflammation have been identified, which may
allow development of biomarkers for rehabilitation.
New neuroplasticity protocols are being used in hu-
mans with SCI, and noninvasive electrophysiology can be
used to guide therapeutic interventions. The corticospinal
tract is an important target for motor recovery after SCI.
Noninvasive techniques have been used to develop tailored
protocols for precise timing of the arrival of descending
and peripheral volleys at corticospinal synapses of upper-
and lower-limb muscles in humans with chronic partial
paralysis. Voluntary motor output depends on the efficacy
of synapses between corticospinal axons and spinal motor
neurons, which can be modulated by precise timing of
central and peripheral neuronal spikes. Thus, noninvasive
techniques can be used to develop tailored protocols for
precise timing of the arrival of descending and peripheral
volleys at corticospinal–spinal motor neuron synapses
involved in intrinsic finger muscle function in humans
with chronic incomplete SCI.
Using electrophysiological measurements by stimu-
lating different levels of the corticospinal pathway in in-
dividual subjects, accurate estimates of the time of arrival
of action potentials to the muscle have been measured;
indeed, latencies of electromyographic responses relied on
the generation of action potentials in motor neurons. The
results indicate that arrival of presynaptic volleys before
motor neuron discharge enhances corticospinal trans-
mission and hand voluntary motor output. In contrast, the
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reverse order of volley arrival and sham stimulation does not
decrease voluntary motor output and electrophysiological
outcomes. Overall, these findings demonstrate that spike
timing–dependent plasticity of residual corticospinal–
spinal motor neuron synapses provides a mechanism to
improve motor function after SCI. Modulation of re-
sidual corticospinal–spinal motor neuron synapses may
present a novel therapeutic target for enhancing voluntary
motor output in motor disorders affecting the cortico-
spinal tract.
The integration of principles and approaches in re-
habilitation science and regenerative medicine may help us
develop innovative and effective methods that promote the
restoration of function through tissue regeneration and
repair. The application of rehabilitation protocols in
combination with cellular therapeutics for the treatment of
injured or diseased tissue enhances transplantation efficacy
and improves functional outcomes. Although it is clear
that the convergence of rehabilitation approaches with
regenerative medicine strategies will accelerate the science
underlying tissue restoration after injury and disease, col-
laborative research efforts across the fields of regenerative
medicine and rehabilitation are greatly lacking. An NIH
RePORTER search of active funding using the Boolean
terms “regenerative medicine” yielded over 2,231 studies.
When we modified this search to include only “physical
medicine and rehabilitation” and “other health profes-
sions,” which include physical therapy, occupational ther-
apy, and speech–language pathology departments, a total of
only 16 grants was displayed. This is remarkable consider-
ing that the promotion of tissue healing and regeneration is
a primary goal of many rehabilitation interventions. There
is, therefore, a great need to expand scientific knowledge,
expertise, and methodologies across the domains of re-
habilitation science and regenerative medicine, with the
ultimate goal of improving the lives of individuals with
disabilities.
Gaps in the understanding of mechanisms underlying
rehabilitation include the following questions: What has
the greatest impact on skeletal muscle strength, the ner-
vous system or the biomechanical manipulation of muscle?
Which stem cell populations can rehabilitation profes-
sionals realistically manipulate? How can exercise influence
the stem cell population? How do bioscaffolds interact with
stem cells? Because the timing of SCI treatment is an
important factor in good outcomes, how will we be able to
translate animal studies into human treatments? What are
the most appropriate strategies for applying regenerative
medicine to rehabilitation? Does the cellular state of the
central nervous system dictate the response to rehabili-
tation treatment, or can the right type of exercise mod-
ify the cellular environment to create permissive learning
conditions?
Bending the Arc of Technology Toward
Rehabilitation and Health
(Moderator: Aiko Thompson, PhD, Medical University of
South Carolina; panelists: Steve Cramer, MD, University of
California, Irvine; James Rimmer, PhD, Lakeshore Foundation;
Susan Magasi, PhD, University of Illinois at Chicago)
The purpose of this session was to discuss how the in-
tegration of technology into rehabilitation, health care,
and wellness services can promote better communication
between health care professionals and patients and thereby
help patients achieve healthy lifestyles and better quality
of life.
The use of information and communication tech-
nologies eliminates distance barriers and can make re-
habilitation and health care services available to people
who have limited access to transportation and other access
issues. In recent years, digital health (e.g., telehealth,
telerehabilitation [telerehab], eHealth [health care services
delivered or enhanced through the Internet], and mHealth
[delivery of health care services via mobile communication
devices]) is becoming a significant part of health care and
the health care economy. Digital health funding has been
steadily increasing. Tools for developing and imple-
menting mobile health care services and research appli-
cations are becoming more and more available. It is clear
that the use of information and communication tech-
nology can broaden rehabilitation and health care research
opportunities for researchers and service opportunities
for patients. In this session, the speakers provided three
levels of remote rehabilitation training management:
full management (by health care professions), middle-level
management, and self-management (by patients). These
different levels are not mutually exclusive but are har-
monious approaches that allow the patient to transition
from one level of management to another, based on his/her
progress in recovery and changes in needs for care and
services.
Many patients do not receive enough dose of rehabili-
tation therapy after stroke. Telerehab is ideally suited to
maximize the gains from therapy; for instance, telerehab can
increase the duration and intensity of therapy and therefore
contribute to greater functional gains. Pilot studies and clinical
trials are ongoing (Cramer) on a home-based telerehab
system for patients with stroke. Telerehab also offers the
option for a holistic approach to patient care, for example,
incorporating education, sensor data collection, and regular
structured interactions with therapists.
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Other technologies such as eHealth and mHealth
can contribute to health promotion emphasizing self-care
rather than expert care. In furthering the view that digital
health technologies can help to overcome existing health
care problems (e.g., lack of integration and coordination
across different disciplines and accessibility barriers), it was
suggested that telerehab may prevent well-known post-
rehabilitation health decline as the patient transitions
from dependence to independence. Preliminary findings
of the ongoing project (Rimmer), “TExT-ME: Telehealth
Exercise Training for Monitoring and Evaluation of Home-
Based Exercise,” show that home-based tele-exercise inter-
ventions can achieve better participant adherence than
conventional onsite exercise programs, leading to better
health benefits. Participants of this tele-exercise program
reported that the convenience and online interaction with
a telecoach enhanced their motivation to attend the sessions.
This telecoaching (i.e., midmanagement) model may
become a precursor to self-management and mHealth for
optimizing recovery in people with neuromuscular
disability.
On the other hand, the expansion of smartphone use
and app design is literally placing sophisticated rehabili-
tation interventions in the hands of people with disabil-
ities. Potential of mRehab applications include symptom
monitoring, real-time data capture, real-time access to
information about navigating the community, social con-
nectedness through peer-to-peer support, and bidirectional
communication. However, there exist barriers to use of
mHealth, such as limited scientific evidence; lack of inte-
gration of multiple perspectives and disciplines into
workflow; concerns over data confidentiality, privacy, and
security; and lack of provisions for reimbursement. Of
particular concern for the disability community is how
factors at the human–technology interface can impose
barriers to use. Accessibility and usability of mRehab in-
terventions are essential factors that must be considered
throughout app development. An iterative interdisciplinary
design process that brings together content, accessibility,
and information technology experts with people with
disabilities can help ensure that the needs and priorities
of the disability community are met.
Many patients after acquiring a disability are unable
to receive the optimal amount of rehabilitation and health
care services because of a number of challenging barriers.
With continuing growth in the use of the Internet and
smartphones, the development of digital health applications
can significantly broaden rehabilitation and health care
opportunities for patients. The full potential of digital health
technologies to reach a large number of people with dis-
abilities who exhibit a range of physical and psychosocial
secondary health conditions and provide them with ef-
fective dose of interventions has yet to be realized.
Transitions Across the Lifespan
(Moderator: Walter Frontera, MD, PhD, Vanderbilt Uni-
versity; panelists: Sharon Ramey, PhD, Virginia Polytechnic
Institute and State University; Ellen Giarelli, EdD, RN, MS,
CRNP, Drexel University; Eric Lenze, MD, Washington
University)
The purpose of this session was to examine current evi-
dence and discuss future research needs in the area of
rehabilitation across the lifespan with a particular empha-
sis on transitions. Disability has an effect on growth and
development, transition to adulthood, and aging (particu-
larly disabling medical conditions). At the same time, these
processes can influence how individuals adapt to the pres-
ence of disability and the nature of their health care needs.
The first presentation focused on the need to increase
the number of implementation science trials to identify
approaches and strategies that work best with a high degree
of certainty. Examples of areas in need of this approach
include studies on cost–benefit ratio and health dispar-
ities. Rapid high-fidelity science is needed to put research
into practice more quickly. In a real-world setting, it is
important to know whether the clinician is familiar with
the latest evidence and the best way to effectively deliver
care with high efficiency and consistency. We need to
understand the barriers and obstacles that prevent research
results from being implemented. In other words, why does
it take so much time and energy to change practice?
Health care, and specifically rehabilitation for patients
with chronic syndromes diagnosed in childhood, in-
cluding those associated with genetic variants, is best
accomplished when it is begun early in life, as soon as a
diagnosis is pending, conceptualized as requiring the in-
tegration of skills, knowledge, and clear intentions of a
diverse team composed of the patient, health care pro-
viders, family members, and other advocates. Tran-
sitioning of any kind can be complicated and is always
highly personal. Furthermore, lifelong management is
complex, requires more health care, and is associated with
higher costs. Therefore, we must use models that capture
sociocultural, environmental, and health variables and
barriers to identify paths to or loci of success. A fundamental
goal is promoting the patient’s skill at self-surveillance and
self-management, including rehabilitation. There are no
tricks, no magic, or failsafe; it is hard work that must be
individualized and supported.
Aging is associated with significant emotional, cog-
nitive, and motivational impairments that interfere with
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successful rehabilitation interventions. Clinical strategies
that focus on patient engagement and therapy intensity
can help with behavioral changes that are needed for
successful rehabilitation. A model of enhanced medical
rehabilitation therapy was presented by Dr. Lenze. This
model includes a package of motivational and high-
intensity therapy steps that physical and occupational
therapists can take to maximize both patient engagement
and therapy intensity. Effort and progress are reinforced
during therapy with direct feedback to the patient, and
therapy is linked to goals set by the patient. Older adults
receiving therapy from enhanced medical rehabilitation–
trained therapists had greater engagement in therapy
sessions, higher patient active time, and better functional
recovery compared with patients receiving typical standard-
of-care therapy.
Novel Outcomes in Rehabilitation and
Integration Into Clinical Care
(Moderator: Jonathan Bean, MD, Harvard Medical School;
panelists: Brad Dicianno, MD, University of Pittsburgh;
Melissa Morrow, PhD, Mayo Clinic; Brian Hafner, PhD,
University of Washington)
The purpose of this session was to examine the clinical and
scientific relevance of developing novel outcomes in re-
habilitation and their potential to favorably impact the
changing health care environment. Health care reform
and the shifting emphasis on managing health have been
coupled with exceptional growth and development in
the application of technology and engineering to health
measurement. As the mobile health field and technologies
evolve, researchers will continuously be presented with
challenges in the conceptual design and deployment of
clinical trials as well as the conduct of clinical care owing to
the vast array of outcomes measures that can be collected.
The Interactive Mobile Health and Rehabilitation
(iMHere) system is an example of a mobile health system
being used to collect ecological momentary assessment
outcomes data among patients with spina bifida (Diciano).
Furthermore, wearable sensors monitoring different as-
pects of health are becoming more widely used in re-
habilitation research as a method of capturing real-world
outcomes. For example, sensor-based outcomes are being
used (Morrow) in SCI rehabilitation research, although
there are challenges to the integration of big data into
clinical practice. New approaches to outcomes measure-
ment have also been applied to the development of
patient-reported outcomes. National initiatives, like the
Patient-Reported Outcomes Measurement Information
System, have resulted in rigorous frameworks for devel-
oping patient-reported outcomes that can evaluate health
outcomes across different patient populations. Efforts
using these same methods to develop an item bank specific
to measuring prosthetic mobility in people with lower-
limb loss were described.
The discussion following the presentations identified a
number of issues and challenges. These included a number
of general issues such as
• The importance of developing a consolidated infra-
structure, be that through industry partnerships or
academic hubs;
• Using that infrastructure to develop systems that in-
tegrate mHealth, wearables, and patient-reported out-
comes in efficient ways so that they complement each
other to optimize assessment and monitoring;
• Developing strategies to incorporate these integrated
data elements into measurement systems with which
patients and clinicians can optimally engage and in-
teract; and
• Integration of the resulting data into the electronic
medical record.
Specific needs that were discussed also included
• Developing standards or best practices for wearable
sensor technology akin to what the Patient-Reported
Outcomes Measurement Information System had done
for patient-reported outcomes;
• Developing strategies for extracting the most impor-
tant data from wearable sensors and presenting them
in a way that is appropriate for the given stakeholder
(patients, practitioners, payers); and
• Using these approaches for more optimal management
of self-care and thus relieving clinicians of the burden
created by interpreting and processing high volumes of
data.
Last, integrated leadership in addressing these concerns
was viewed as a priority for NIH, especially in cooper-
ation with other relevant agencies such as the Patient-
Centered Outcomes Research Institute, the Agency for
Healthcare Research and Quality, and the Veterans
Health Administration.
Using Data to Drive Discovery
(Moderator: Ken Ottenbacher, PhD, University of Texas
Medical Branch; panelists: Adrian Hernandez, MD, Duke
University; James Graham, PhD, University of Texas
Medical Branch; Jennifer Hicks, PhD, Stanford University)
The purpose of this session was to examine the use of data
as a means to drive discovery. Using data to drive discovery
has been a hallmark of scientific investigation since the
1600s, beginning with the writings of Sir Francis Bacon
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regarding the modern scientific method. How data have
been defined and used to generate new knowledge has
evolved dramatically since then. The pace has been par-
ticularly rapid during the past decade. This revolution is
being driven by several factors, including (1) advances in
information technology, (2) the development of sophis-
ticated data analytics, and (3) the increased availability and
complexity of data. These factors provide opportunities for
data integration, exploration, and secondary analysis that
did not exist even a few years ago. The NIH “Big Data”
program, referred to as BD2K (Big Data to Knowledge)
and launched in 2012, is a reflection of the data revolution
and its impact on biomedical and health care sciences. For
the fields of rehabilitation medicine and disability sciences
to fully participate in the research opportunities associated
with using data to drive discovery, there is a need to raise
awareness and build research capacity.
Significant opportunities exist for data exploration
and analyses in existing administrative and federal data
sets, including resources supported by the NIH specifically
designed for rehabilitation investigators, for example,
Center for Large Data Research and Data Sharing in
Rehabilitation. In addition, the Mobilize Center, an NIH
BD2K Center of Excellence, is using modern data science
tools to integrate and analyze information from wearable
sensors, research laboratories, and clinics to understand
and improve human mobility—for example, to improve
treatment of patients with CP. The NIH-funded Na-
tional Center for Simulation in Rehabilitation Research
provides the worldwide rehabilitation research community
with a common platform for sharing data and models that
describe movement.
Additional opportunities for discovery exist using large
administrative or public use databases such as Medicare
claims and assessment files and U.S. Census data (including
data related to the Patient Protection and Affordable Care
Act and health care reform). There are rapidly emerging
opportunities for information sharing and secondary
analyses of data from completed studies associated with
recent federal data sharing and archiving mandates. The use
of electronic health records and the creation of large data
networks and a health system collaboratory represent yet
another opportunity to use clinical data with an emphasis
on patient-reported and patient-centered outcomes. Ex-
amples included the NIH Collaboratory, the National
Heart, Lung, and Blood Institute’s Heart Failure Clinical
Research Network; and PCORnet, the National Patient-
Centered Clinical Research Network, which includes data
from more than 100 million people.
Using data to drive discovery is an important and
rapidly expanding area of research with enormous po-
tential to advance rehabilitation science and patient care.
This session provided an introduction to the emerging
discipline of data science and its application and impli-
cations for rehabilitation research. A better understanding
of data science will help rehabilitation clinicians, ad-
ministrators, and investigators accomplish the confer-
ence’s goal of “moving the field forward.”
Preventing Secondary Disability
(Moderator: Diane Damiano, PhD, PT, NIH Clinical
Center; panelists: Greg Hicks, PhD, University of Delaware;
Diann Gaalema, PhD, University of Vermont; Sara Mulroy,
PhD, Rancho Los Amigos National Rehabilitation Center)
This session focused on major issues in prevention of
secondary disability across four distinct populations.
children with CP, older adults with low back pain, adults
with SCI, and adults recommended for cardiac rehabili-
tation programs. Even with this diversity, many similarities
were seen across the presentations.
The scientific basis across populations for addressing
secondary impairments focuses on the identification of
modifiable factors that, if addressed, would improve
outcomes in terms of health and functioning for these
individuals. For children with CP, the focus is on physical
activity throughout the lifespan to preserve and maintain
optimal muscle and brain functioning. A particular em-
phasis is the need to intervene very early in life to limit the
development of secondary changes due to the inactivity
imposed by the brain lesion.
For older adults with low back pain, trunk muscle
integrity has been identified as a key modifiable factor in
this population that can reduce pain. Interestingly, pain was
previously thought to be an almost inevitable part of normal
aging, so much so that older adults were typically excluded
from studies on low back pain. The patients at highest risk
for poor outcomes after cardiac surgery are often those
who are least likely to attend rehabilitation programs, which
have been shown to be efficacious in improving outcomes.
It is important to identify why these individuals choose not
to attend with the goal of devising strategies to improve
their participation. Compliance with rehabilitation or with
long-term behavioral health changes was a theme that
resonated across speakers and with the audience. Efforts
to incentivize patients to participate, while expensive, may
reduce health care costs tremendously if successful.
Another patient population with secondary disability
is that of people with SCIs with shoulder injuries. Using
sophisticated biomechanical analyses, movement patterns
that markedly diminished shoulder pain have been iden-
tified, again showing that research is needed on modifiable
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factors that enable people to remain or increase their ability
to be mobile, whether it is in a wheelchair or walking in the
community. It was emphasized that patients should have
greater involvement in our research so we can learn their
concerns and challenges and their individual factors that
make them more likely to have adverse health outcomes. In
some instances, it can be socioeconomic status; in Southern
California, living in a violent neighborhood markedly in-
creased the chances of having an SCI, [a correlation that]
presents unique and specific public health challenges in
addition to the scientific challenges.
Future recommendations for research are to better
engage patients and their needs in research efforts and to
be more open to alternative methodologies besides RCTs
to find cost-effective methods to help people maintain
their health across the lifespan. From a more translational
science perspective, we need to know more about mech-
anisms leading to pain across disorders and continue to
explore biomechanical and motor learning/training strat-
egies to improve functionality and reduce pain rather than
masking the chronic pain with medication. For children
with CP, effective early intervention strategies need more
investigation, while the intersection of aging with dis-
ability is also a major gap in the literature.
Finally, secondary disability is hardly secondary in cost,
duration, and importance to patients. However, because it
occurs as a result of a primary injury, these could theo-
retically all be avoidable, or at least modifiable, and this is
where rehabilitation research is needed.
Development of an NIH Rehabilitation
Research Plan
(Presenters: Alison Cernich and Lyn Jakeman)
This session covered the development of the new NIH Re-
habilitation Research Plan. The intent of the plan is to detail
research priorities that are of interest to a large group of the
institutes and centers in the NIH that invest in rehabilitation
research. A trans-NIH Medical Rehabilitation Research Co-
ordinating Committee began development of the plan in
2015. They developed the priorities in the plan in consultation
with the National Advisory Board on Medical Rehabilitation
Research and the directors of the NIH institutes and centers.
NIH published a draft of the plan asking for public comment
inNovember of 2015 and revised the plan based on that input.
Through feedback received through the request for
public input, the Medical Rehabilitation Research Co-
ordinating Committee modified the plan to include the
development of new methods to foster interdisciplinary
research, placing greater emphasis on health disparities
and broadening the avenues for development of new
technologies. As a result of the comments, the Medical
Rehabilitation Research Coordinating committee added
two priority areas and revised and refined other priority
areas. The final plan includes six priority areas: (1) re-
habilitation across the lifespan, (2) family and community,
(3) technology use and development, (4) translational
science, (5) research design and methodology, and (6)
research capacity and infrastructure. The plan was
intended to be final in June, and a town hall meeting at
the conference provided the final opportunity for feedback
to the Medical Rehabilitation Research Coordinating
committee before the plan was published. s
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